Cargando…
Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
Melanoma is the most aggressive skin cancer and its incidence is gradually increasing worldwide. Patients with metastatic melanoma have a very poor prognosis (estimated 5-year survival rate of <16%). In the last few years, several drugs have been approved for malignant melanoma, such as tyrosine...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Association of Immunologists
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411510/ https://www.ncbi.nlm.nih.gov/pubmed/25922594 http://dx.doi.org/10.4110/in.2015.15.2.58 |